FDA Clearance Tracker · P050038-S001
ARISTA AH ABSORBABLE HEMOSTAT
Last checked: Nov 20, 2026Latest source record: Jun 6, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Jun 6, 2007
Approved
Time to decision
36 days
Received May 1, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P050038-S001
- Device name
- ARISTA AH ABSORBABLE HEMOSTAT
- Applicant
- Davol, Inc.
- Applicant location
- Warwick, RI
- Received
- May 1, 2007
- Decided
- Jun 6, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P050038
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE REMOVAL OF THE UROLOGICAL PROCEDURES EXCLUSION FROM THE INDICATIONS STATEMENT.
Source documents
Other decisions for Davol, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261543 · Decided Sep 28, 2026 · 143 days after receipt
Device type: Mesh, Surgical, Absorbable, Abdominal Hernia (OWT) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.